ArticleCPT: pharmacometrics & systems pharmacology2021

Population pharmacokinetic model with time-varying clearance for lorlatinib using pooled data from patients with non-small cell lung cancer and healthy participants.

Joseph Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.